logo

Phasebio Pharmaceuticals Inc (PHAS)



Trade PHAS now with
  Date
  Headline
2/13/2020 4:03:16 PM PhaseBio Appoints Alex Sapir To Board Of Directors
8/14/2019 7:21:23 AM PhaseBio Announces Receipt Of Minutes Of End-of-Phase 1 Meeting With The FDA For Potential U.S. Approval Of PB2452
8/13/2019 4:03:47 PM PhaseBio Pharma Q2 Loss/share $0.33 Vs. Loss $8.95 Year Ago
12/17/2018 4:32:10 PM PhaseBio Appoints Edmund Harrigan To Board Of Directors
11/27/2018 8:08:34 AM PhaseBio Unveils Dosing Of First Patient In Phase 2b Trial Of PB1046 In Pulmonary Arterial Hypertension